HOW DO PSA-BASED MARKERS PREDICT CLINICALLY SIGNIFICANT PROSTATE CANCER (CSPCA) ON PROSTATE BIOPSY INDEPENDENT OF PROSTATE SIZE

被引：0
|
作者：
Kuster, Max
Ou, Michelle
Gaines, Jacob
Macdonald, Eric
Hall, Simon
机构：
来源：
JOURNAL OF UROLOGY | 2022年 / 207卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP53-12
引用
收藏
页码：E899 / E900
页数：2
相关论文
共 50 条
  • [31] PSA-based screening for prostate cancer after renal transplantation
    Malavaud, B
    Hoff, M
    Miédouge, M
    Rostaing, L
    TRANSPLANTATION, 2000, 69 (11) : 2461 - 2462
  • [32] Unintended consequences of decreased PSA-based prostate cancer screening
    Thomas Ahlering
    Linda My Huynh
    Kamaljot S. Kaler
    Stephen Williams
    Kathryn Osann
    Jean Joseph
    David Lee
    John W. Davis
    Ronney Abaza
    Jihad Kaouk
    Vipul Patel
    Isaac Yi Kim
    James Porter
    Jim C. Hu
    World Journal of Urology, 2019, 37 : 489 - 496
  • [33] Lymphocyte-to-monocyte ratio is a predictor of clinically significant prostate cancer at prostate biopsy
    Cho, Min Chul
    Yoo, Sangjun
    Choo, Min Soo
    Son, Hwancheol
    Jeong, Hyeon
    PROSTATE, 2021, 81 (16): : 1278 - 1286
  • [34] UNINTENDED CONSEQUENCES OF DECREASED PSA-BASED PROSTATE CANCER SCREENING
    Ahlering, Thomas
    Huynh, Linda
    Kamaljot, Kaler
    Williams, Stephen
    Osann, Kathryn
    Joseph, Jean
    Lee, David
    Davis, John
    Abaza, Ronney
    Kaouk, Jihad
    Patel, Vipul
    Kim, Isaac
    Porter, James
    Hu, Jim
    JOURNAL OF UROLOGY, 2018, 199 (04): : E1108 - E1109
  • [35] PSA-based screening for prostate cancer: How does it compare with other cancer screening tests?
    Crawford, E. David
    Abrahamsson, Per-Anders
    EUROPEAN UROLOGY, 2008, 54 (02) : 262 - 273
  • [36] AN AI DRIVEN APPROACH TO PREDICT THE OUTCOME OF PROSTATE BIOPSY: IDENTIFYING CANCER, CLINICALLY SIGNIFICANT DISEASE, AND UNFAVORABLE PATHOLOGICAL FEATURES ON PROSTATE BIOPSY
    Pasat-Karasik, Cristina
    Davenport, Lily
    Pfail, John
    Gabriele, Marla
    Gerenia, Mae
    Schlussel, Kacie
    Haas, Ian
    Berryhill, Roy
    Choudhury, Samia
    Ratnani, Parita
    Shukla, Bhavya
    Wagaskar, Vinayak
    Wiklund, Peter
    Lundon, Dara
    Tewari, Ashutosh
    JOURNAL OF UROLOGY, 2021, 206 : E499 - E499
  • [37] Multiparametric MRI Fusion-Guided Prostate Biopsy for Detection of Clinically Significant Prostate Cancer Eliminates the Systemic Prostate Biopsy
    Matulevicius, Augustinas
    Bakavicius, Arnas
    Ulys, Albertas
    Trakymas, Mantas
    Usinskiene, Jurgita
    Naruseviciute, Ieva
    Sabaliauskaite, Rasa
    Zukauskaite, Kristina
    Jarmalaite, Sonata
    Jankevicius, Feliksas
    APPLIED SCIENCES-BASEL, 2022, 12 (19):
  • [38] Prostate-specific antigen (PSA) and PSA velocity: Competitors or collaborators in the prediction of curable and clinically significant prostate cancer
    D'Amico, Anthony V.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (06) : 823 - 824
  • [39] Optimal biopsy approach for detection of clinically significant prostate cancer
    Ippoliti, Simona
    Fletcher, Peter
    Orecchia, Luca
    Miano, Roberto
    Kastner, Christof
    Barrett, Tristan
    BRITISH JOURNAL OF RADIOLOGY, 2022, 95 (1131):
  • [40] Detection of clinically significant cancer in the anterior prostate by transperineal biopsy
    Cowan, Tim
    Baker, Emily
    McCray, Gabriella
    Reeves, Fairleigh
    Houlihan, Kimberley
    Johns-Putra, Lydia
    BJU INTERNATIONAL, 2020, 126 : 33 - 37
12345